The disrupted amino acid metabolism exacerbates CCl4-induced liver fibrosis by promoting the release of fibrotic mediators from T cells, including TGF-β, IL-4, IL-6 and IL-17 (Yoshizaki et al., 2010; Shan et al., 2016). Here, TGFB1 is linked to Hepatic fibrosis.